中药药理学家李连达院士逝世

2018-10-19 佚名 中国中医科学院

我国著名中药药理学家、中国工程院院士、中国中医科学院首席研究员李连达同志因病医治无效,于2018年10月18日11时55分在北京逝世,享年84岁。


我国著名中药药理学家、中国工程院院士、中国中医科学院首席研究员李连达同志因病医治无效,于2018年10月18日11时55分在北京逝世,享年84岁。

李连达,1934年7月24日出生于辽宁省沈阳市。1956年毕业于北京医学院医疗系,后到中国中医科学院西苑医院工作。1956-1974年在西苑医院从事中医儿科临床工作,1974年开始从事中药药理学研究工作。先后担任西苑医院基础医学研究室主任、中国中医科学院首席研究员、中国中医科学院医学实验中心主任、博士生导师、博士后指导老师、著名中医药学专家、第六批全国老中医药专家学术经验继承工作指导老师、国家药典委员会委员。中央国家机关“五一劳动奖章”获得者,第八、九、十届全国政协委员。

李连达在中药药理学领域做出重要贡献。建立我国中药药效学评价标准及技术规范,在国内首先建立了一些新的研究方法,并在全国推广应用。阐明“血瘀证”的科学内涵及“活血化瘀”治疗的基本规律与作用机理,该项研究获得国家科技进步一等奖。首创中药与自体骨髓干细胞经心导管输入冠状动脉移植于心脏治疗冠心病的新方法。他是我国中药药理学专业最具影响力的专家之一,他的工作对中药药理学研究影响深远。

李连达曾获得国家科技进步一等奖、卫生部甲级科技成果奖、中华中医药学会一等奖等各级多项奖励。他培养硕士、博士、博士后等50余人,多人已成为中医药研究领域的学术骨干。

李连达具有强烈的爱国心,他对中医药文化有着深刻的认识,并通过自己的科研工作为祖国中西医结合事业做出了重要贡献。

李连达同志永垂不朽!

李连达同志遗体告别仪式定于2018年10月22日上午8时在北京市八宝山殡仪馆东礼堂举行。

治丧事宜联系人:徐峰13810649223项国梁13488714113

唁电请发至中国中医科学院,传真:010-64007743

李连达同志治丧工作小组

2018年10月18日

附:

李连达院士生平

李连达(1934.7.24-2018.10.18)沈阳人。1956年毕业于北京医学院医疗系,分配到西苑医院工作至今。现任中国中医科学院首席研究员,著名中医药学专家学术经验传承博士后指导老师、第六批全国老中医药专家学术经验继承工作指导老师、国家药典委员会委员;中央国家机关“五一劳动奖章”获得者,第八、九、十届全国政协委员。

1974年创建西苑医院基础医学研究室,在国内首次建立心肌细胞培养方法,首次建立多种血瘀证动物模型,研究经典古方和地奥心血康等新药,阐明“活血化瘀”治疗的基本规律;1991年在卫生部领导下,组织制定了我国中药药效学评价标准与技术规范,提高了中药新药的研究水平。

主持十五国家科技攻关计划课题、973课题、国家自然科学基金面上项目等多项研究课题,获得国家科技进步一等奖、卫生部甲级科技成果奖、中华中医药学会一等奖等各级多项奖励。主编出版《中医药研究》、《孺子牛-院士直言》多部专著,发表学术论文300多篇,培养硕士、博士、博士后等50余人,多人已成为中医药研究领域的学术骨干。

2003年当选为中国工程院院士。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1797128, encodeId=23e51e9712867, content=<a href='/topic/show?id=cdd2225146c' target=_blank style='color:#2F92EE;'>#中药药理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22514, encryptionId=cdd2225146c, topicName=中药药理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Tue Nov 27 04:50:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797131, encodeId=e6a41e971317a, content=<a href='/topic/show?id=e3892251693' target=_blank style='color:#2F92EE;'>#中药药理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22516, encryptionId=e3892251693, topicName=中药药理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Wed Apr 10 14:50:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675008, encodeId=737816e5008db, content=<a href='/topic/show?id=d25361456f7' target=_blank style='color:#2F92EE;'>#李连达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61456, encryptionId=d25361456f7, topicName=李连达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=857027156668, createdName=zhangph, createdTime=Fri Jan 25 14:50:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516177, encodeId=33b915161e7e8, content=<a href='/topic/show?id=7e868e9126b' target=_blank style='color:#2F92EE;'>#药理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87912, encryptionId=7e868e9126b, topicName=药理学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=300b10929379, createdName=ms7019579240139182, createdTime=Sun Oct 21 12:50:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049018, encodeId=230d1049018c5, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Oct 20 00:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1797128, encodeId=23e51e9712867, content=<a href='/topic/show?id=cdd2225146c' target=_blank style='color:#2F92EE;'>#中药药理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22514, encryptionId=cdd2225146c, topicName=中药药理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Tue Nov 27 04:50:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797131, encodeId=e6a41e971317a, content=<a href='/topic/show?id=e3892251693' target=_blank style='color:#2F92EE;'>#中药药理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22516, encryptionId=e3892251693, topicName=中药药理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Wed Apr 10 14:50:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675008, encodeId=737816e5008db, content=<a href='/topic/show?id=d25361456f7' target=_blank style='color:#2F92EE;'>#李连达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61456, encryptionId=d25361456f7, topicName=李连达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=857027156668, createdName=zhangph, createdTime=Fri Jan 25 14:50:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516177, encodeId=33b915161e7e8, content=<a href='/topic/show?id=7e868e9126b' target=_blank style='color:#2F92EE;'>#药理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87912, encryptionId=7e868e9126b, topicName=药理学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=300b10929379, createdName=ms7019579240139182, createdTime=Sun Oct 21 12:50:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049018, encodeId=230d1049018c5, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Oct 20 00:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1797128, encodeId=23e51e9712867, content=<a href='/topic/show?id=cdd2225146c' target=_blank style='color:#2F92EE;'>#中药药理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22514, encryptionId=cdd2225146c, topicName=中药药理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Tue Nov 27 04:50:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797131, encodeId=e6a41e971317a, content=<a href='/topic/show?id=e3892251693' target=_blank style='color:#2F92EE;'>#中药药理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22516, encryptionId=e3892251693, topicName=中药药理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Wed Apr 10 14:50:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675008, encodeId=737816e5008db, content=<a href='/topic/show?id=d25361456f7' target=_blank style='color:#2F92EE;'>#李连达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61456, encryptionId=d25361456f7, topicName=李连达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=857027156668, createdName=zhangph, createdTime=Fri Jan 25 14:50:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516177, encodeId=33b915161e7e8, content=<a href='/topic/show?id=7e868e9126b' target=_blank style='color:#2F92EE;'>#药理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87912, encryptionId=7e868e9126b, topicName=药理学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=300b10929379, createdName=ms7019579240139182, createdTime=Sun Oct 21 12:50:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049018, encodeId=230d1049018c5, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Oct 20 00:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=)]
    2019-01-25 zhangph
  4. [GetPortalCommentsPageByObjectIdResponse(id=1797128, encodeId=23e51e9712867, content=<a href='/topic/show?id=cdd2225146c' target=_blank style='color:#2F92EE;'>#中药药理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22514, encryptionId=cdd2225146c, topicName=中药药理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Tue Nov 27 04:50:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797131, encodeId=e6a41e971317a, content=<a href='/topic/show?id=e3892251693' target=_blank style='color:#2F92EE;'>#中药药理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22516, encryptionId=e3892251693, topicName=中药药理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Wed Apr 10 14:50:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675008, encodeId=737816e5008db, content=<a href='/topic/show?id=d25361456f7' target=_blank style='color:#2F92EE;'>#李连达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61456, encryptionId=d25361456f7, topicName=李连达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=857027156668, createdName=zhangph, createdTime=Fri Jan 25 14:50:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516177, encodeId=33b915161e7e8, content=<a href='/topic/show?id=7e868e9126b' target=_blank style='color:#2F92EE;'>#药理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87912, encryptionId=7e868e9126b, topicName=药理学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=300b10929379, createdName=ms7019579240139182, createdTime=Sun Oct 21 12:50:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049018, encodeId=230d1049018c5, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Oct 20 00:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1797128, encodeId=23e51e9712867, content=<a href='/topic/show?id=cdd2225146c' target=_blank style='color:#2F92EE;'>#中药药理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22514, encryptionId=cdd2225146c, topicName=中药药理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Tue Nov 27 04:50:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797131, encodeId=e6a41e971317a, content=<a href='/topic/show?id=e3892251693' target=_blank style='color:#2F92EE;'>#中药药理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22516, encryptionId=e3892251693, topicName=中药药理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Wed Apr 10 14:50:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675008, encodeId=737816e5008db, content=<a href='/topic/show?id=d25361456f7' target=_blank style='color:#2F92EE;'>#李连达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61456, encryptionId=d25361456f7, topicName=李连达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=857027156668, createdName=zhangph, createdTime=Fri Jan 25 14:50:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516177, encodeId=33b915161e7e8, content=<a href='/topic/show?id=7e868e9126b' target=_blank style='color:#2F92EE;'>#药理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87912, encryptionId=7e868e9126b, topicName=药理学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=300b10929379, createdName=ms7019579240139182, createdTime=Sun Oct 21 12:50:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049018, encodeId=230d1049018c5, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Oct 20 00:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=)]
    2018-10-20 junJUN

    院士是学术至高点,也是大家必争之地呀

    0

相关资讯

中国工程院院士中药专家李连达谈活熊取胆

 过去杀熊取胆汁,以供药用,有消灭种群之虑。近年各动物保护组织,对珍稀濒危动物加强保护、严禁捕杀,十分必要。但有些情况需要从实际出发加以考虑。   我们反对为了商业目的,杀象取象牙,杀犀牛取犀角,制造工艺品,谋取暴利;我们反对为了娱乐,猎杀珍稀动物;我们也反对为了食用熊掌、猴脑、鱼翅而捕杀熊、猴及鲨鱼等,甚至造成物种灭绝。   但是为了治病救人,我们可以取用人血(成千上万的献血者多次取血),

李连达:毕生奉献中医药

从事中医临床和基础研究60余年,上世纪80年代,在国内建立动物和人的心肌细胞培养方法,并用于中药研究向全国推广,至今仍在国内普遍使用;90年代,在卫生部领导下,负责制定了我国第一个中药药效学评价标准与技术规范,成为我国第一个官方认可的中药药效学评价标准及技术规范,迄今仍为全国遵守的标准;2000年以来,首创中药与自体骨髓干细胞经心导管移植治疗冠心病的新方法。

李连达院士:掌握好临床与科研的平衡

一部分医生以科研为主是可以的,但绝大多数医生应以治病救人的临床工作为主。培养医学人才的大方向不能离轨近年来,有的医院过度强调科研,过度重视建设科研型医院,过度提倡医生成为科研型医生,评出了一些“不会看病的高水平医生”。有的医学硕博士、教授及医学专家只重视搞科研、写文章,却不太会看病。医生该不该做科研?这是一个带有普遍性的重要问题,也是亟待解决的方向性、导向性问题。医学科研很重要,能够让医生不断更新